Stocks and Investing
Stocks and Investing
Wed, June 21, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Vikram Purohit Reiterated (SLRN) at Buy and Held Target at $29 on, Jun 21st, 2023
Vikram Purohit of Morgan Stanley, Reiterated "Acelyrin, Inc." (SLRN) at Buy and Held Target at $29 on, Jun 21st, 2023.
Vikram has made no other calls on SLRN in the last 4 months.
There are 3 other peers that have a rating on SLRN. Out of the 3 peers that are also analyzing SLRN, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Vikram
- Akash Tewari of "Jefferies" Initiated at Strong Buy and Held Target at $31 on, Tuesday, May 30th, 2023
- Tyler Van Buren of "TD Cowen" Initiated at Buy on, Tuesday, May 30th, 2023
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $68 on, Tuesday, May 30th, 2023
Contributing Sources